PHARMACY PROFESSIONS IN INDIA: PRESENT STATUS, FUTURE CHALLENGES AND A WAY FORWARD
People in every country became exposed to COVID-19 pandemic and cannot able to find a right solution and strategies to overcome from it. Pharmacy is the most important, dynamic and versatile health care profession in the world, whereas its scope and importance are always being emerging at any situation.1 Pharmacy professionals (PPs) working proactively for the public even in this pandemic situation. Since dependency is high, the responsibility and preference also high for PPs especially in this pandemic situation. Current status in pharmacy education and emerging future challenges of PPs in all aspects particularly in this COVID-19 pandemic were addressed based on observational studies among various pharma industries and published news of Pharmacy Council of India (PCI). While in the development phase it has to cross many barriers, not only in the economic level it also involves regulations, duration, process controls, legal hurdles and situational defects. The purpose of this review discusses the evolution and updates in pharmacy, education, pharmacy practice, regulations, and types of challenges along with recommendations for PPs in India in light of the COVID-19 pandemic.
2. Basak SC, Sathyanarayana D. Community pharmacy practice in India: past, present and future. South Med Review 2009;2:11-4.
3. Rotta I, Salgado TM, et al. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. Journal of Evaluation in Clinical Practice 2015;21:584-90.
4. Mohanan M, Hay K, Mor N. Quality of health care in India: Challenges, priorities, and the road ahead. Health Affairs 2016;35:1753-8.
5. MoHFW. Home; 2020. Available from: https://www.mohfw.gov.in/.
6. Lakshminarayanan S. Role of government in public health: current scenario in India and future scope. Journal of Family Community Medicine 2016;18:26-30.
7. Kalaiselvan V, Srivastava, S, Singh A. et al. Pharmacovigilance in India: Present Scenario and Future Challenges. Drug Safety 2019;42:339-46.
8. Palsokar G, Tajne M. Postgraduate research in pharmaceutical sciences in India: a survey of select pharmacy professionals. International Journal of Current Pharmaceutical Research 2017;9:161-4.
9. Jose, J., Rafeek, N.R. Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives. Therapeutic Innovation and Regulatory Science 2019;53:781-6.
10. Mohanan M, Hay K, Mor N. Quality of health care in India: Challenges, priorities, and the road ahead. Health Affairs 2016;35:1753-8.
11. Vignesh M, Ganesh GNK. Current status, challenges and preventive strategies to overcome data integrity issues in the pharmaceutical industry. International Journal of Applied Pharmaceutics 2020;12(6).
12. Supreme court of India, Union of India vs. M.V. Mohanan Nair; 2020. Available from: https://indiankanoon.org/doc/55062525/
13. Kishore J. Legislation and health promotion in India. Review of Global Medicine and Healthcare Research 2012;37:75-87.
14. Ramalingam Peraman, Hari Hara Theja Dugga. Need for the Refinement of Licensing Procedure for Pharmacists in India. Journal of Young Pharmacist 2016;8:293.
15. Lakshminarayanan S. Role of government in public health: current scenario in India and future scope. Journal Family and Community Medicine 2016;18:26-30.
16. Peter Roderick, Rushikesh Mahajan, et al. India should introduce a new Drugs Act. The Lancet 2014;383:203-6.
17. Daniel Bennett, Wesley Yin. The Market for High-Quality Medicine: Retail Chain Entry and Drug Quality in India. The Review of Economics and Statistics 2019;101:76-90.
18. Peter Roderick, Rushikesh Mahajan, et al. India should introduce a new Drugs Act. The Lancet 2014;383:203-6.
19. Agarwal Praveen, Bhandary Deepak, Rasheed Abdul. Drug approval procedure in India (CDSCO). Research & Reviews: A Journal of Drug Design & Discovery 2015;2:20-6.
20. Daniel Bennett, Wesley Yin. The Market for High-Quality Medicine: Retail Chain Entry and Drug Quality in India. The Review of Economics and Statistics 2019;101:76-90.
21. Pravat kumar J. Impact of pandemic COVID-19 on education in India. International Journal of Current Research 2020;12:12582-6.
22. World Health Organization. Coronavirus disease (COVID-19) outbreak situation; 2020 Available from: https://www.who.int/emergencies/diseases/novel-coronavir us-2019.
23. Hedima EW, Adeyemi MS, Ikunaiye NY. Community pharmacists: on the frontline of health service against COVID-19 in LMICs. Research in Social and Administrative Pharmacy 2020;19:30381-8.
24. Carolina Oi Lam Ung. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Research in Social and Administrative Pharmacy 2020;16:583-6.
25. Mukattash TL, Jarab AS, et al. Pharmacists’ perception of their role during COVID-19: a qualitative content analysis of posts on Facebook pharmacy groups in Jordan. Pharmacy Practice 2020;18:1900.
26. Shrimali, Gireesh, Retna Kumar, Aravind. Battery Storage Manufacturing in India: A Strategic Perspective; 2020. Available at SSRN: https://ssrn.com/abstract=3616404
27. Usha Sharma. Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy. Express pharma; 2020. Available from: https://www.expresspharma.in/latest-updates/pharma-cos-should-develop-strategies-to-develop-apis-and-making-india-self-reliant-dr-eswara-reddy/
28. Department of pharmaceuticals. PLI Scheme for Pharmaceuticals and Medical devices; 2020. Available from:https://pharmaceuticals.gov.in/schemes#:~:text=Download%20(1.6%20MB)-,Production%20Linked%20Incentive%20(PLI)%20Scheme%20for%20promotion%20of%20domestic%20manufacturing,Promotion%20of%20Bulk%20Drug%20Parks.
29. Mansukh Mandaviya. Covid-19: Centre chalks out four schemes to boost production of bulk drugs and medical devices; 2020. Available from: https://economictimes.indiatimes.com/news/economy/policy/covid-19-centre-chalks-out-four-schemes-to-boost-production-of-bulk-drugs-and-medical-devices/articleshow/74867468.cms?from=mdr
30. Anyachebelu O, Aluh D. Pharmacists compliance to practice regulations and good professional practice: a case study of Nigerian community pharmacists. International Journal of Pharmacy and Pharmaceutical Sciences 2018;10:98-104.
31. Shahrawat R, Rao KD. Insured yet vulnerable: out-of-pocket payments and India’s poor. Health Policy Plan 2012;27:213-21.
32. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian Journal of Pediatrics 2020; 87:281-6.
33. Mackey et al. Fit-for-purpose? - challenges and opportunities for applications of blockchain technology in the future of healthcare. BMC Medicine 2019;17:1-17.
34. Vignesh M, Ganesh GNK. Fixed Dose Combinations Banned in India - A Review. Journal of Pharmaceutical Sciences and Research 2020;12:987-91.
35. Aiswarya Vijayan. Digital India - A Roadmap to Sustainability. International Journal of Innovative Technology and Exploring Engineering 2019;8:571-6.
36. Nedungadi P.P, Menon R, Gutjahr G, Erickson L, Raman R. Towards an inclusive digital literacy framework for digital India. Education + Training 2018;60:516-28.
37. Snyder ME, Jaynes HA, et al. Factors associated with comprehensive medication review completion rates: a national survey of community pharmacists. Research in Social and Administrative Pharmacy 2020;16:673-80.
38. Rajubhai L Pargi. Implication and impact of digital education system in India. International Journal of Humanities & Social Science: Insights & Transformations 2019;4:1-6.
39. Vignesh M, Ganesh GNK. Generic prescription in India - A review. Asian Journal of Pharmaceutical and Clinical Research 2020;13:20-4.
40. Nandini G, Anitha K. An intelligent pharmacy and health care services. Journal of Critical Reviews 2020;7:1820-6.
This work is licensed under a Creative Commons Attribution 4.0 International License.